These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25420639)

  • 1. The national biomarker development alliance: confronting the poor productivity of biomarker research and development.
    Poste G; Compton CC; Barker AD
    Expert Rev Mol Diagn; 2015 Feb; 15(2):211-8. PubMed ID: 25420639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biospecimens, biomarkers, and burgeoning data: the imperative for more rigorous research standards.
    Poste G
    Trends Mol Med; 2012 Dec; 18(12):717-22. PubMed ID: 23122852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The National Biomarker Development Alliance accelerating the translation of biomarkers to the clinic.
    Barker AD; Compton CC; Poste G
    Biomark Med; 2014; 8(6):873-6. PubMed ID: 25224942
    [No Abstract]   [Full Text] [Related]  

  • 4. Personalized medicine: elusive dream or imminent reality?
    Lesko LJ
    Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical neuroproteomics and biomarkers: from basic research to clinical decision making.
    Shoemaker LD; Achrol AS; Sethu P; Steinberg GK; Chang SD
    Neurosurgery; 2012 Mar; 70(3):518-25. PubMed ID: 21866062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-overcoming barriers in translating biomarkers to clinical practice.
    Staratschek-Jox A; Schultze JL
    Expert Opin Med Diagn; 2010 Mar; 4(2):103-12. PubMed ID: 23484444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical perspectives of personalized healthcare in oncology.
    Hodgson DR; Wellings R; Harbron C
    N Biotechnol; 2012 Sep; 29(6):656-64. PubMed ID: 22426411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
    Lee JW; Figeys D; Vasilescu J
    Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systems biology meets -omic technologies: novel approaches to biomarker discovery and companion diagnostic development.
    Caberlotto L; Lauria M
    Expert Rev Mol Diagn; 2015 Feb; 15(2):255-65. PubMed ID: 25362968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers: refining diagnosis and expediting drug development - reality, aspiration and the role of open innovation.
    Salter H; Holland R
    J Intern Med; 2014 Sep; 276(3):215-28. PubMed ID: 24605903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translational research: precision medicine, personalized medicine, targeted therapies: marketing or science?
    Marquet P; Longeray PH; Barlesi F; ; Ameye V; Augé P; Cazeneuve B; Chatelut E; Diaz I; Diviné M; Froguel P; Goni S; Gueyffier F; Hoog-Labouret N; Mourah S; Morin-Surroca M; Perche O; Perin-Dureau F; Pigeon M; Tisseau A; Verstuyft C
    Therapie; 2015; 70(1):1-19. PubMed ID: 25679189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of sepsis.
    Marshall JC; Reinhart K;
    Crit Care Med; 2009 Jul; 37(7):2290-8. PubMed ID: 19487943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network views for personalized medicine.
    Vlahou A
    Proteomics Clin Appl; 2013 Jun; 7(5-6):384-7. PubMed ID: 23532915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in pediatrics: children as biomarker orphans.
    Savage WJ; Everett AD
    Proteomics Clin Appl; 2010 Dec; 4(12):915-21. PubMed ID: 21137032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breaking a vicious cycle.
    Hayes DF; Allen J; Compton C; Gustavsen G; Leonard DG; McCormack R; Newcomer L; Pothier K; Ransohoff D; Schilsky RL; Sigal E; Taube SE; Tunis SR
    Sci Transl Med; 2013 Jul; 5(196):196cm6. PubMed ID: 23903752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translation of neurological biomarkers to clinically relevant platforms.
    Hayes RL; Robinson G; Muller U; Wang KK
    Methods Mol Biol; 2009; 566():303-13. PubMed ID: 20058180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema.
    Ptolemy AS; Rifai N
    Scand J Clin Lab Invest Suppl; 2010; 242():6-14. PubMed ID: 20515269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualizing asthma therapy: application of biomarkers.
    Szefler SJ
    J Asthma; 2008; 45 Suppl 1():29-31. PubMed ID: 19093283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies.
    Miossec P; Verweij CL; Klareskog L; Pitzalis C; Barton A; Lekkerkerker F; Reiter S; Laslop A; Breedveld F; Abadie E; Flamion B; Dere W; Mpofu S; Goel N; Ethgen D; Mitlak B; Ormarsdóttir S; Rao R; Tsouderos Y; Reginster JY;
    Ann Rheum Dis; 2011 Oct; 70(10):1713-8. PubMed ID: 21784723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From bench to MS bedside: challenges translating biomarker discovery to clinical practice.
    Rajasekharan S; Bar-Or A;
    J Neuroimmunol; 2012 Jul; 248(1-2):66-72. PubMed ID: 22381245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.